MIDATECH PHARMA
About Us | Strategy

Midatech’s strategy is to expand its US commercial presence as well as develop its platform technologies into multiple products in order to achieve multiple potential revenue opportunities. Its business model has three key components:

Its commercialisation strategy is to build an enduring, profitable and commercially focused enterprise with revenues generated as follows:

Midatech has the opportunity to leverage its US commercial platform and roll out similar infrastructure in Europe to coincide with the market entry of its pipeline oncology products.

About Us
Strategy

Midatech’s strategy is to expand its US commercial presence as well as develop its platform technologies into multiple products in order to achieve multiple potential revenue opportunities. Its business model has three key components:

Its commercialisation strategy is to build an enduring, profitable and commercially focused enterprise with revenues generated as follows:

Midatech has the opportunity to leverage its US commercial platform and roll out similar infrastructure in Europe to coincide with the market entry of its pipeline oncology products.

© Copyright 2017 Midatech Pharma PLC